Search results
Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report - Pfizer...
Benzinga· 15 hours agoIn a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc....
Investing in Pfizer Inc.
Knox Daily· 4 days agoIn the deal valued at $26.47 per share,3,000 shares were bought. As a result of this transaction...shares worth roughly $0.25 million. Argus downgraded ...
7 Cheap Value Stocks to Buy Now: May 2024
InvestorPlace· 1 day agoThe major stock market indexes are near record highs. The good news, however, is that investors can still put money to work in today’s market without...
Top Stock Reports for Amazon.com, Visa & Pfizer
Zacks via Yahoo Finance· 6 days agoMarietta (MLM), Weather Woes Ail Per the Zacks analyst, robust infrastructure demand, efficient implementation of SOAR... analyst is impressed with...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 2 days agoShares now have a top Relative Strength Rating of 99. The RS Rating pits all stocks, regardless of...
One stock is dragging down the S&P 500's earnings growth
Yahoo Finance via AOL· 3 days agoPfizer (PFE) and Gilead Sciences (GILD). Gilead Sciences reported a loss per share of $1.32 in the...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 1 day agoIn the first quarter, Halozyme earned an adjusted 79 cents per share on $196 million in sales, up a...
7 F-Rated Stock Picks to Avoid Like the Plague in May
InvestorPlace· 6 days agoThe stock market is off to a washing machine kind of start for 2024, with gains and lulls that keep...
Unveiling Viatris (VTRS)'s Value: Is It Really Priced Right? A C
Guru Focus· 2 days agoWith a Loss Per Share of 0.06, the question arises: is Viatris modestly overvalued? This article delves into a detailed valuation analysis...make informed ...
Amid Biotech Pitfalls, This Stock Has Outperformed Nvidia in the Last 3 Months
Investing.com· 3 days agoAmid Biotech Pitfalls, This Stock Has Outperformed Nvidia in the Last 3 Months
